Impact of collaborative clinician visits on postdischarge total cost of care in a polypharmacy population

Medicine & Life Sciences

• Polypharmacy 100%
• Pharmacists 58%
• Costs and Cost Analysis 50%
• Population 32%
• Primary Health Care 11%
• Physician Assistants 9%
• Nurse Practitioners 8%
• Patient Readmission 8%
• Ambulatory Care 7%
• Hospital Emergency Service 5%
• Inpatients 5%
• Retrospective Studies 4%
• Physicians 4%
• Pharmaceutical Preparations 3%

Social Sciences

• pharmacist 73%
• clinician 69%
• costs 46%
• hospital discharge 24%
• physician 12%
• outpatient care 12%
• cost reduction 11%
• clinical outcomes 11%
• adverse events 11%
• assistant 7%
• medication 7%
• nurse 6%
• drug 5%
• regression 5%
• Group 4%

Chemical Compounds

• Drug 43%
• Reduction 37%